Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ambra Vittoria Gualeni"'
Autor:
Mélanie A. Cron, Solène Maillard, Frédérique Truffault, Ambra Vittoria Gualeni, Annunziata Gloghini, Elie Fadel, Julien Guihaire, Anthony Behin, Sonia Berrih-Aknin, Rozen Le Panse
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Autoimmune Myasthenia gravis (MG) is a chronic neuromuscular disease mainly due to antibodies against the acetylcholine receptor (AChR) at the neuromuscular junction that induce invalidating muscle weaknesses. In early-onset MG, the thymus is the eff
Externí odkaz:
https://doaj.org/article/b6d141d3817a49a789604c5f7906f8e5
Autor:
Ilaria Bossi, Alessandra Castano, Filippo de Braud, Maria di Bartolomeo, Ambra Vittoria Gualeni, Chiara Costanza Volpi, Alessandro Inno, Annunziata Gloghini, Manuela Gariboldi, Claudia Maggi, Pamela Biondani, Juan Carlos Samamé Pérez-Vargas, Filippo Pietrantonio
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 18056-18077 (2013)
Mesenchymal-epithelial transition (MET) is a member of a distinct subfamily of heterodimeric receptor tyrosine kinase receptors that specifically binds the hepatocyte growth factor (HGF). Binding to HGF leads to receptor dimerization/multimerization
Externí odkaz:
https://doaj.org/article/2444ef04fffe41ab9ec9d7495d32775c
Autor:
Federica Di Nicolantonio, Filippo de Braud, Alberto Bardelli, Maria Di Bartolomeo, Federica Perrone, Giulia Siravegna, Alessandra Alessi, Ambra Vittoria Gualeni, Federica Morano, Adele Busico, Marta Caporale, Ludovic Barault, Rosa Berenato, Emanuele Valtorta, Annunziata Gloghini, Daniele Oddo, Filippo Pietrantonio
Supplementary Table S1. List of genes and exons analyzed by targeted next-generation sequencing. Supplementary Table S2. Summary of molecular data from the ISH and sequencing analyses conducted on both the pre-treatment primary tumor and the liver bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81dd726549a11865a144ca577a732988
https://doi.org/10.1158/2159-8290.22530914
https://doi.org/10.1158/2159-8290.22530914
Autor:
Federica Di Nicolantonio, Filippo de Braud, Alberto Bardelli, Maria Di Bartolomeo, Federica Perrone, Giulia Siravegna, Alessandra Alessi, Ambra Vittoria Gualeni, Federica Morano, Adele Busico, Marta Caporale, Ludovic Barault, Rosa Berenato, Emanuele Valtorta, Annunziata Gloghini, Daniele Oddo, Filippo Pietrantonio
Supplementary Figure S1. Copy number increase of MDM2 gene at progression after vemurafenib+panitumumab. Supplementary Figure S2. Representative examples of colorectal carcinomas bearing BRAF mutations and MET gene copy number gain. Supplementary Fig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c656d8368ec3478a43b0bea6919b3ce
https://doi.org/10.1158/2159-8290.22530917.v1
https://doi.org/10.1158/2159-8290.22530917.v1
Autor:
Federica Di Nicolantonio, Filippo de Braud, Alberto Bardelli, Maria Di Bartolomeo, Federica Perrone, Giulia Siravegna, Alessandra Alessi, Ambra Vittoria Gualeni, Federica Morano, Adele Busico, Marta Caporale, Ludovic Barault, Rosa Berenato, Emanuele Valtorta, Annunziata Gloghini, Daniele Oddo, Filippo Pietrantonio
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43d3c14045e6514c66125156c0be94b
https://doi.org/10.1158/2159-8290.22530920.v1
https://doi.org/10.1158/2159-8290.22530920.v1
Autor:
Maria Di Bartolomeo, Chiara Cremolini, Silvia Giordano, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa, Lorenzo Castagnoli, Alessandro Pellegrinelli, Maria Antista, Michele Prisciandaro, Salvatore Corallo, Maria Maddalena Laterza, Chiara Costanza Volpi, Elisa Giommoni, Adele Busico, Elena Ongaro, Ambra Vittoria Gualeni, Gianluca Tomasello, Elena Tamborini, Ferdinando De Vita, Federica Perrone, Giuseppe Aprile, Simona Corso, Annunziata Gloghini, Federica Morano, Giovanni Fucà, Filippo Pietrantonio
Definition of trastuzumab resistant (A) and trastuzumab sensitive (B) patients according to combined assessment of RECIST response and time to progression to trastuzumab plus cisplatin/fluoropyrimidine induction treatment given for up to 6 cycles and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466ae1c4ff24afe683f598b64b726394
https://doi.org/10.1158/1078-0432.22465010
https://doi.org/10.1158/1078-0432.22465010
Autor:
Maria Di Bartolomeo, Chiara Cremolini, Silvia Giordano, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa, Lorenzo Castagnoli, Alessandro Pellegrinelli, Maria Antista, Michele Prisciandaro, Salvatore Corallo, Maria Maddalena Laterza, Chiara Costanza Volpi, Elisa Giommoni, Adele Busico, Elena Ongaro, Ambra Vittoria Gualeni, Gianluca Tomasello, Elena Tamborini, Ferdinando De Vita, Federica Perrone, Giuseppe Aprile, Simona Corso, Annunziata Gloghini, Federica Morano, Giovanni Fucà, Filippo Pietrantonio
Online Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084a8371fb3551be8a313e9e7ae9d1f7
https://doi.org/10.1158/1078-0432.22465004.v1
https://doi.org/10.1158/1078-0432.22465004.v1
Autor:
Maria Di Bartolomeo, Chiara Cremolini, Silvia Giordano, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa, Lorenzo Castagnoli, Alessandro Pellegrinelli, Maria Antista, Michele Prisciandaro, Salvatore Corallo, Maria Maddalena Laterza, Chiara Costanza Volpi, Elisa Giommoni, Adele Busico, Elena Ongaro, Ambra Vittoria Gualeni, Gianluca Tomasello, Elena Tamborini, Ferdinando De Vita, Federica Perrone, Giuseppe Aprile, Simona Corso, Annunziata Gloghini, Federica Morano, Giovanni Fucà, Filippo Pietrantonio
Purpose: Refining the selection of HER2-positive metastatic gastric cancer patient candidates for trastuzumab is a challenge of precision oncology. Preclinical studies have suggested several genomic mechanisms of primary resistance, leading to activa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ddc1a623fcf3a1c33e6082f099621b5
https://doi.org/10.1158/1078-0432.c.6525896
https://doi.org/10.1158/1078-0432.c.6525896
Autor:
Maria Di Bartolomeo, Chiara Cremolini, Silvia Giordano, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa, Lorenzo Castagnoli, Alessandro Pellegrinelli, Maria Antista, Michele Prisciandaro, Salvatore Corallo, Maria Maddalena Laterza, Chiara Costanza Volpi, Elisa Giommoni, Adele Busico, Elena Ongaro, Ambra Vittoria Gualeni, Gianluca Tomasello, Elena Tamborini, Ferdinando De Vita, Federica Perrone, Giuseppe Aprile, Simona Corso, Annunziata Gloghini, Federica Morano, Giovanni Fucà, Filippo Pietrantonio
Kaplan Meier estimates of PFS according to HER2 IHC expression (2+ versus 3+) in patients molecularly selected by the AMNESIA panel, i.e. in absence of EGFR/MET/KRAS/PI3K mutations and EGFR/MET/KRAS amplifications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52e920bf22a457dbc45df10cd8ec4ae2
https://doi.org/10.1158/1078-0432.22465007
https://doi.org/10.1158/1078-0432.22465007
Autor:
Maria Di Bartolomeo, Chiara Cremolini, Silvia Giordano, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa, Lorenzo Castagnoli, Alessandro Pellegrinelli, Maria Antista, Michele Prisciandaro, Salvatore Corallo, Maria Maddalena Laterza, Chiara Costanza Volpi, Elisa Giommoni, Adele Busico, Elena Ongaro, Ambra Vittoria Gualeni, Gianluca Tomasello, Elena Tamborini, Ferdinando De Vita, Federica Perrone, Giuseppe Aprile, Simona Corso, Annunziata Gloghini, Federica Morano, Giovanni Fucà, Filippo Pietrantonio
Prevalence of alterations not included in the AMNESIA panel, reported by means of NGS from resistant (cases) versus sensitive (controls) patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d0368a1ed044a60a2eceff111b5892
https://doi.org/10.1158/1078-0432.22465001.v1
https://doi.org/10.1158/1078-0432.22465001.v1